Senators target insulin price rise with bipartisan proposal
Click here to view this article at the source publication

Posted on 7/26/2019 by
Posted in

A group of senators says it has a plan to reduce insulin prices with legislation intended to hold pharmaceutical companies and insurance companies more accountable.

The proposal’s called the Insulin Price Reduction Act and its sponsors say it would incentivize reductions in list prices. The senators say in a statement the plan would hold “health care middlemen” such as pharmacy benefit managers accountable.

« Back home